Nomoto H, Gurlo T, Girgis M, Dry SM, Rosenberger M, Butler PC.
Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes.
Case Reports in Endocrinology. 2019.
Nomoto H, Gurlo T, Girgis M, Dry SM, Rosenberger M, Butler PC.
Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes.
Case Reports in Endocrinology. 2019.
Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Diabetes, Obesity and Metabolism. 2019. PMID: 31486230
Cho KY, Nakamura A, Oba-Yamamoto C, Tsuchida K, Yanagiya S, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.
Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
Diabetes & Metabolism Journal. 2019. PMID: 31769240
Montemurro C*, Nomoto H*, Pei L*, Vongbunyong KE, Vadrevu S, Gurlo T, Butler AE, Subramaniam R, Ritou E, Shirihai OS, Satin LS, Butler PC, Tudzarova S. IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function. Nat Commun. 2019. PMID: 31213603 (*: joint first authors)
Sekizaki T, Kameda H, Oba C, Cho KY, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation. Endocr J, in press
Miya A, Nakamura A, Kameda H, Nozu K, Miyoshi H, Atsumi T. Gitelman’s Syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report. Medicine, in press
Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y. The protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease, and type 2 diabetes. J Diabetes Investig in press. (PMID: 31026373)
Miyazaki T, Shirakawa J, Nagakura J, Shibuya M, Kyohara M, Okuyama T, Togashi Y, Nakamura A, Kondo Y, Satoh S, Nakajima S, Taguri M, Terauchi Y. Influence of timing of insulin initiation on long-term glycemic control in Japanese patients with type 2 diabetes: a retrospective cohort study. Intern Med, in press
Sato M, Miyoshi H, Nakamura A, Sumi N, Kamoshima H, Ono Y. Cross-cultural adaptation of the chronic illness resources survey in Japanese patients with diabetes. Jpn J Nurs Sci, in press
Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi R, Hatanaka KC, Terauchi Y, Atsumi T. Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. Metabolism, in press (PMID: 31202833)